1,684
Views
225
CrossRef citations to date
0
Altmetric
Review

Zebrafish assays for drug toxicity screening

Pages 231-240 | Published online: 24 Mar 2006

Bibliography

  • RODEN DM: Drug-induced prolongation of the QT interval. N. Engl. J. Med. (2004) 350:1013-1022.
  • KONSTANTINOPOULOS PA, LEHMANN DF: The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding. J. Clin. Pharmacol. (2005) 45:742-750.
  • PETERSON RT, LINK BA, DOWLINGJE, SCHREIBER SL: Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA (2000) 97:12965-12969.
  • SPITSBERGEN JM, KENT ML: The state of the art of the zebrafish model for toxicology and toxicologic pathology research-advantages and current limitations. Toxicol. Pathol. (2003) 31:62-87.
  • NASEVICIUS A, EKKER SC: Effective targeted gene knockdown in zebrafish. Nat. Genet. (2000) 26:216-220.
  • DRAPER BW, MORCOS PA, KIMMELCB: Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown. Genesis (2001) 30:154-156.
  • DODD A, CHAMBERS SP, LOVE DR: Short interfering RNA-mediated gene targeting in the zebrafish. FEBS Lett. (2004) 561:89-93.
  • LIU WY, WANG Y, SUN YH et al.: Efficient RNA interference in zebrafish embryos using siRNA synthesized with SP6 RNA polymerase. Dev. Growth Differ. (2005) 47:323-331.
  • URTISHAK KA, CHOOB M, TIAN X et al.: Targeted gene knockdown in zebrafish using negatively charged peptide nucleic acid mimics. Dev. Dyn. (2003) 228:405-413.
  • HAFFTER P, GRANATO M, BRAND M etal.: The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development (1996) 123:1-36.
  • DRIEVER W, SOLNICA-KREZEL L, SCHIER AF etal.: A genetic screen for mutations affecting embryogenesis. Development (1996) 123:37-46.
  • BLADER P, STRAHLE U: Ethanol impairs migration of the prechordal plate in the zebrafish embryo. Dev. Biol. (1998) 201:185-201.
  • CARVAN MJ, LOUCKS E, WEBER DN, WILLIAMS FE: Ethanol effects on the developing zebrafish: neurobehavior and skeletal morphologenesis. Neurotoxicol. Teratol. (2004) 26:757-768.
  • BILOTTA J, SASZIK S, GIVIN CM, HARDESTY HR, SUTHERLAND SE: Effects of embryonic exposure to ethanol on zebrafish visual function. Neurotoxicol. Teratol. (2002) 24:759-766.
  • VAN LEEUWEN CJ, GROOTELAAREMM, NIEBEEK G: Fish embryos as teratogenicity screens: a comparison of embryotoxicity between fish and birds. Ecotoxicol. Environ. Saf. (1990) 20:42-52.
  • GURVICH N, BERMAN MG, WITTNER BS, GENTLEMAN RC, KLEIN PS, GREEN JB: Association of valproate-induced teratogenesis with histone deacetylase inhibition invivo. FASEB J. (2005) 19:1166-1168.
  • CUNLIFFE VT: Histone deacetylase 1 is required to repress Notch target gene expression during zebrafish neurogenesis and to maintain the production of motoneurones in response to hedgehog signalling. Development (2004) 131:2983-2995.
  • PILLAI R, COVERDALE LE, DUBEY G, MARTIN CC: Histone deacetylase 1 (HDAC-1) required for the normal formation of craniofacial cartilage and pectoral fins of the zebrafish. Dev. Dyn. (2004) 231:647-654.
  • BAKER K, WARREN KS, YELLEN G, FISHMAN MC: Defective pacemaker current (Ih) in a zebrafish mutant with a slow heart rate. Proc. Natl. Acad. Sci. USA (1997) 94:4554-4559.
  • SEHNERT AJ, STAINIER DY: A window to the heart: can Zebrafish mutants help us understand heart disease in humans? Trends Genet. (2002) 18:491-494.
  • SEHNERT AJ, HUQ A, WEINSTEINBM, WALKER C, FISHMAN M, STAINIER DY: Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat. Genet. (2002) 31:106-110.
  • XU X, MEILER SE, ZHONG TP etal.: Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat. Genet. (2002) 30:205-209.
  • SCHONBERGER J, WANG L, SHIN JT etal.: Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat. Genet. (2005) 37:418-422.
  • HENRY TR, SPITSBERGEN JM, HORNUNG MW, ABNET CC, PETERSON RE: Early life stage toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish (Danio rerio). Toxicol. Appl. Pharmacol. (1997) 142:56-68.
  • MILAN DJ, PETERSON TA, RUSKINJN, PETERSON RT, MACRAECA: Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 107:1355-1358.
  • ANTKIEWICZ DS, BURNS CG, CARNEY SA, PETERSON RE, HEIDEMAN W: Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol. Sci. (2005) 84:368-377.
  • PETERSON RT, MABLEY JD, CHENJN, FISHMAN MC: Convergence of distinct pathways to heart patterning revealed by the small molecule concentramide and the mutation heart-and-soul. Curr. Biol. (2001) 11:1481-1491.
  • WITCHEL HJ, MILNES JT, MITCHESON JS, HANCOX JC: Troubleshooting problems with invitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. J. Pharmacol. Toxicol. Meth. (2002) 48:65-80.
  • ECKARDT L, HAVERKAMP W, BORGREFFE M, BREITHARD G: Experimental models of Torsades de Pointe. Cardiovasc. Res. (1998) 39:178-193.
  • LANGHEINRICH U, VACUN G, WAGNER T: Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol. Appl. Pharmacol. (2003) 193:370-382.
  • BURNS CG, MILAN DJ, GRANDE EJ, ROTTBAUER W, MACRAE CA, FISHMAN MC: High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat. Chem. Biol. (2005) 1:263-264.
  • HUANG CJ, TU CT, HSIAO CD, HSIEHFJ, TSAI HJ: Germ-line transmission of a myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin light chain 2 promoter of zebrafish. Dev. Dyn. (2003) 228:30-40.
  • MOENS CB, PRINCE VE: Constructing the hindbrain: insights from the zebrafish. Dev. Dyn. (2002) 224:1-17.
  • LEWIS KE, EISEN JS: From cells to circuits: development of the zebrafish spinal cord. Prog. Neurobiol. (2003) 69:419-449.
  • WILSON SW, BRAND M, EISEN JS: Patterning the zebrafish central nervous system. Results Probl. Cell Differ. (2002) 40:181-215.
  • LANGSTON JW, BALLARD P: Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science (1983) 219:979-980.
  • FORNAI F, VAGLINI F, MAGGIO R, BONUCCELLI U, CORSINI GU: Species differences in the role of excitatory amino acids in experimental parkinsonism. Neurosci. Biobehav. Rev. (1997) 21:401-435.
  • BRETAUD S, LEE S, GUO S: Sensitivity of zebrafish to environmental toxins implicated in Parkinsons disease. Neurotoxicol. Teratol. (2004) 26:857-864.
  • LAM CS, KORZH V, STRAHLE U: Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur. J. Neurosci. (2005) 21:1758-1762.
  • MCKINLEY ET, BARANOWSKI TC, BLAVO DO, CATO C, DOAN TN, RUBINSTEIN AL: Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res. Mol. Brain Res. (2005) 141:128-137.
  • GUO S, WILSON SW, COOKE S, CHITNIS AB, DRIEVER W, ROSENTHAL A: Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev. Biol. (1999) 208:473-487.
  • HOLZSCHUH J, RYU S, ABERGER F, DRIEVER W: Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech. Dev. (2001) 101:237-243.
  • MENG A, TANG H, ONG BA, FARRELLMJ, LIN S: Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2. Proc. Natl. Acad. Sci. USA (1997) 94:6267-6272.
  • PARK HC, KIM CH, BAE YK etal.: Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons. Dev. Biol. (2000) 227:279-293.
  • HIGASHIJIMA S, HOTTA Y, OKAMOTO H: Visualization of cranial motor neurons in live transgenic expressing GFP under the control of the Islet-1 promoter/enhancer. J. Neurosci. (2000) 20:206-218.
  • GAMSE JT, THISSE C, THISSE B, HALPERN ME: The parapineal mediates left-right asymmetry in the zebrafish diencephalon. Development (2003) 130:1059-1068.
  • SAINT-AMANT L, DRAPEAU P: Time course of the development of motor behaviors in the zebrafish embryo. J. Neurobiol. (1998) 37:622-632.
  • BEHRA M, ETARD C, COUSIN X, STRAHLE U: The use of zebrafish mutants to identify secondary target effects of acetylcholine esterase inhibitors. Toxicol. Sci. (2004) 77:325-333.
  • TIEDEKEN JA, RAMSDELL JS, RAMSDELL AF: Developmental toxicity of domoic acid in zebrafish. Neurotoxicol. Teratol. (2005) 27:711-717.
  • GRANATO M, VAN EEDEN FJM, SCHACH U etal.: Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. Development (1996) 23:399-413.
  • BARABAN SC, TAYLOR MR, CASTROPA, BAIER H: Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience (2005) 131:759-768.
  • SEARFOSS GH, JORDAN WH, CALLIGARO DO etal.: Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional -secretase inhibitor. J. Biol. Chem. (2003) 278:46107-46116.
  • MILANO J, MCKAY J, DAGENAIS C etal.: Modulation of Notch processing by -secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol. Sci. (2004) 82:341-358.
  • WONG GT, MANFRA D, POULET FM etal.: Chronic treatment with the -secretase inhibitor LY-411,575 inhibits -amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J. Biol Chem. (2004) 279:12876-12882.
  • GELING A, STEINER H, WILLEM M, BALLY-CUIF L, HAASS C: A -secretase inhibitor blocks Notch signaling invivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. (2002) 3:688-694.
  • PETIT A, PASINI A, ALVES DA COSTA C etal.: JLK isocoumarin inhibitors: Selective -secretase inhibitors that do not interfere with notch pathway invitro or invivo. J. Neurosci. Res. (2003) 74:370-377.
  • GHYSEN A, DAMBLY-CHAUDIERE C: Development of the zebrafish lateral line. Curr. Opin. Neurobiol. (2004) 14:67-73.
  • TON C, PARNG The use of zebrafish for assessing ototoxic and otoprotective agents. Hear. Res. (2005) 208:79-88.
  • WALLACE KN, PACK M: Unique and conserved aspects of gut development in zebrafish. Dev. Biol. (2005) 255:12-29.
  • HUANG H, LIU N, LIN S: Pdx-1 knockdown reduces insulin promoter activity in zebrafish. Genesis (2001) 30:134-136.
  • FIELD HA, OBER EA, ROESER T, STAINIER DYR: Formation of the digestive system in zebrafish. I. Liver morphogenesis. Dev. Biol. (2003) 253:279-290.
  • FARBER SA, PACK M, HO SY etal.: Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science (2001) 292:1385-1388.
  • STRMAC M, BRAUNBECK T: Effects of triphenyltin acetate on survival, hatching success, and liver ultrastructure of early life stages of zebrafish (Danio rerio). Ecotoxicol. Environ. Saf. (1999) 44:25-39.
  • AMANUMA K, TAKEDA H, AMANUMA H, AOKI Y: Transgenic zebrafish for detecting mutations caused by compounds in aquatic environments. Nat. Biotech. (2000) 18:62-65.
  • AMANUMA K, NAKAMURA T, AOKI Y: MNNG-induced mutations in the adult gill and hepatopancreas and in embryos of rpsL transgenic zebrafish. Mut. Res. (2004) 556:151-161.
  • BECKWITH LG, MOORE JL, TSAO-WU GS, HARSHBARGER JC, CHENG KC: Ethylnitrosourea induces neoplasia in zebrafish (Danio rerio). Lab. Invest. (2000) 80:379-385.
  • SPITSBERGEN JM, TSAI HW, REDDYA, et al.: Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages. Toxicol. Pathol. (2000) 28:716-725.
  • LINNEY E, UPCHURCH L, DONERLYS: Zebrafish as a neurotoxicological model. Neurotoxicol. Teratol. (2004) 26:709-718.
  • PICHLER FB, LAURENSON S, WILLIAMS LC, DODD A, COPP BR, LOVE DR: Chemical discovery and global gene expression analysis in zebrafish. Nature Biotech. (2003) 21:879-883.
  • VAN DER VEN K, DE WIT M, KEIL D et al.: Development and application of a brain-specific cDNA microarray for effect evaluation of neuro-active pharmaceuticals in zebrafish (Danio rerio). Comp. Biochem. Physiol. B Biochem. Mol. Biol. (2005) 141:408-417.
  • BRESOLIN T, REBELO MF, BAINYACD: Expression of PXR, Cyp3A and MDR1 genes in liver of zebrafish. Comp. Biochem. Physiol. Part C (2005) 140:403-407.
  • TSENG HP, HSEU TH, BUHLER DR, WANG WD, HU CH: Constitutive and xenobiotics-induced expression of a novel CYP3A gene from zebrafish larva. Toxicol. Appl. Pharmacol. (2005) 205:247-258.
  • TERAOKA H, DONG W, TSUJIMOTOY etal.: Induction of cytochrome P450 1A is required for circulation failure and edema by 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish. Biochem. Biophys. Res. Commun. (2003) 304:223-228.
  • WANG-BUHLER JL, LEE SJ, CHUNGWG etal.: Cloning, mapping, developmental/tissue expression, and aflatoxin B1 activation by baculovirus expressed enzyme. Comp. Biochem. Physiol. C Toxicol. Pharmacol. (2005) 40:207-219.
  • CALLARD GV, TCHOUDAKOVA AV, KISHIDA M, WOOD E: Differential tissue distribution, developmental programming, estrogen regulation and promoter characteristics of cyp19 genes in teleost fish. Steroid Biochem. Mol. Biol. (2001) 79:305-314.
  • ZHAO Q, DOBBS-MCAULIFFE B, LINNEY E: Expression of cyp26B1 during zebrafish early development. Gene Expr. Patt. (2005) 5:363-369.
  • CARVAN MJ 3rd, DALTOM TP, STUART GW, NEBERT DW: Transgenic zebrafish as sentinels for aquatic pollution. Ann. NY Acad. Sci. (2000) 919:133-147.
  • SETINI A, PIERUCCI F, SENATORI O, NICOTRA A: Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Comp. Biochem. Physiol. B (2005) 140:153-161.

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.